3968
A. Inoue et al. / Tetrahedron Letters 51 (2010) 3966–3968
In summary, we have completed the first total synthesis of opti-
OMOM
OMOM
O
cally pure (+)-aspermytin A (1) using a diastereoselective Me2AlCl-
mediated IMDA reaction and a substrate-controlled construction of
an allylic quaternary stereogenic center as the key steps. In addi-
tion, the absolute structure of aspermytin A was unambiguously
established by total synthesis. Our synthetic studies described here
may contribute to the development of a new type of anti-Alzhei-
mer agents.
H
H
H
H
a, b
c
d
15
20
21
OMOM
CHO
H
H
H
H
O
+
O
e, f
g
3
Acknowledgments
3
19
We thank Professor Sachiko Tsukamoto of Kumamoto University
for providing us with the spectral data (1H and 13C NMR) of aspermy-
tin A. We also thank the Takasago International Co. for the generous
gift of citronellal. This work was supported financially by a Grant-in-
Aid for the Program for Promotion of Basic and Applied Research for
Innovations in the Bio-oriented Industry (BRAIN).
O
H
HO
H
i
h
OH
R
22
(+)-1
H
H
24
22: R=α-OH
23: R=β-OH
References and notes
Scheme 5. Reagents and conditions: (a) H2, Pd–C, EtOH, 96%; (b) nBu3P, o-nitro-
phenyl selenocyanate then 30% H2O2 (aq), NaHCO3, THF, quant.; (c) O3, Me2S,
MeOH, CH2Cl2, 87%; (d) IBX, DMSO, toluene; (e) 6 N HCl, THF; (f) DMP, CH2Cl2, 75%
from 21; (g) MeLi, THF, 80% for 22, 11% for 23; (h) TPAP, NMO, 4 Å MS, CH2Cl2, 92%;
(i) LDA, (1H-benzo[d][1,2,3]triazol-1-yl)methanol, THF, 95%.
1. Tsukamoto, S.; Miura, S.; Yamashita, Y.; Ohta, T. Bioorg. Med. Chem. Lett. 2004,
14, 417.
2. Yuki, K.; Shindo, M.; Shishido, K. Tetrahedron Lett. 2001, 42, 2517.
3. For a review, see: Takao, K.; Munakata, R.; Tadano, K. Chem. Rev. 2005, 105,
4779.
4. Takai, K.; Kunisada, Y.; Tachibana, Y.; Yamaji, N.; Nakatani, E. Bull. Chem. Soc.
Jpn. 2004, 77, 1581.
5. For a review, see: Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
6. Polt, R.; Sames, D.; Chruma, J. J. Org. Chem. 1999, 64, 6147; Maleczka, R. E., Jr.;
Gallagher, W. P. Org. Lett. 2001, 26, 4173.
7. Roush, W. R.; Gills, H. R.; Ko, A. I. J. Am. Chem. Soc. 1982, 104, 2269.
8. Taber, D. F.; Saleh, S. A. J. Am. Chem. Soc. 1980, 102, 5085.
9. For a review, see: Chen, B. C.; Zhou, P.; Davis, F. A.; Ciganek, E. Org. React. 2003,
62, 1.
10. These were obtained as an inseparable mixture of two diastereoisomers.
11. Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem. 1976, 41, 1485.
12. Nicolaou, K. C.; Zhong, Y. L.; Baran, P. S. J. Am. Chem. Soc. 2000, 122, 7596.
13. Deguest, G.; Bischoff, L.; Fruit, C.; Marsais, F. Org. Lett. 2007, 9, 1165.
14. The synthetic aspermytin A was obtained as colorless needles, mp 122.2–
122.7 °C (recrystallization from n-hexane).
C13 quaternary stereogenic center was realized. Oxidation of 22
with TPAP and NMO in the presence of 4 Å MS provided the
hydroxy ketone 24 as a single product in 92% yield. Finally, the
aldol condensation using LDA and (1H-benzo[d][1,2,3]triazol-1-
yl)methanol13 proceeded cleanly to give aspermytin A (1) in 95%
yield. The spectral data of synthetic aspermytin A were fully con-
sistent with those of the natural product. We attribute the differ-
ence in the magnitude of the optical rotation data {½a D28
ꢂ
+7.6 (c
0.97, CHCl3); lit. ½a D25
ꢂ
+1.2 (c 0.102, CHCl3)} to that of the synthetic
material having a much higher level of purity14 (Scheme 5).